“When Robert Wood came to Harvard University 17 years ago, he wanted to design an insect-sized robot that could fly,” reports the Boston Globe. And finally Last month, technology from Wood’s “RoboBee” project was commercialized for the first time, “spi…

The rate of people dying from cancer in the United States has continuously declined over the past three decades, according to a new report from the American Cancer Society. CNN reports: The US cancer death rate has fallen 33% since 1991, which correspo…

New medicines need not be tested in animals to receive U.S. Food and Drug Administration (FDA) approval, according to legislation signed by President Joe Biden in late December 2022. Science Magazine reports: “This is huge,” says Tamara Drake, director…

“To date, about 500 people have been put in cryogenic stasis after legal death,” writes a Bloomberg Opinion technology columnist, “with the majority of them in the U.S.

“But a few thousand more, including Emil Kendziorra, are on waiting lists, wearin…

The Food and Drug Administration on Friday approved a new Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease, but also carries risks of swelling and bleeding in the brain. From a report: The approval of the drug,…

An anonymous reader quotes a report from The Register: Askern Medical Practice, a general practitioner surgery based in Doncaster, UK, managed to muddle its Christmas holiday message to patients by texting them they’d been diagnosed with “aggressive lu…

An anonymous reader quotes a report from Ars Technica: Immune therapies have rewritten the game when it comes to cancer treatment, earning the “fifth pillar” label next to more tried and true treatments like radiation therapy, surgery, and chemotherapy…

Long-time geriatrician James Kirkland is a Mayo clinic researcher joining “a growing movement to halt chronic disease by protecting brains and bodies from the biological fallout of aging,” reports Ars Technica.

“While researchers like Kirkland don’t …